STAMFORD, Conn., June 13, 2011 /PRNewswire/ -- MKM Partners today announced that Jon LeCroy, M.D., has joined as a Managing Director in its Equity Research department to cover biotechnology and specialty pharmaceuticals companies, inaugurating MKM's research expansion into the healthcare sector.
Dr. LeCroy covered the same sector at Hapoalim Securities USA most recently and at Natixis Bleichroeder and Goldman Sachs before that. He ranked #5 in this year's Wall Street Journal Best on the Street poll in Biotechnology. Dr. LeCroy holds an MBA from Boston University's Graduate School of Management, an M.D. from University of South Florida College of Medicine and a B.S. in biology from Wake Forest University. He will be based in MKM's Stamford headquarters.
"I am excited about the opportunity to join MKM Partners and plan to build on the firm's previous success by expanding research coverage into the healthcare industry," Jon remarked.
"Our move into the healthcare vertical expands MKM's research footprint," said MKM Partners CEO Richard R. Castellano. "Jon's in-depth and actionable research – and his stockpicking prowess – will make him a key resource for MKM's existing institutional equity client base and enable us to service new clients focused on investment opportunities in healthcare."
ABOUT MKM PARTNERS
MKM Partners is an institutional equity research, sales and trading firm. Headquartered in Stamford, Connecticut, with offices in New York City, Boston and across the U.S., MKM provides clients with actionable and unbiased economic, technical, derivatives, event-driven and fundamental research and has trade execution abilities in U.S. and foreign equity markets and in U.S. options markets. In addition to offering timely access to its traders and analysts, MKM focuses on delivering exceptional service to institutional clients across its trading and research platforms. More information about MKM Partners can be accessed at www.mkmpartners.com.
For more information, contact:
Richard R. Castellano, CEO
|SOURCE MKM Partners|
Copyright©2010 PR Newswire.
All rights reserved